Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial.
Galactionova K, Loibl S, Salari P, Marmé F, Martin M, Untch M, Bonnefoi HR, Kim SB, Bear HD, McCarthy N, Gelmon KA, García-Sáenz JA, Kelly CM, Reimer T, Toi M, Rugo HS, Gnant M, Makris A, Burchardi N, Schwenkglenks M.
Galactionova K, et al. Among authors: salari p.
Front Oncol. 2022 Sep 5;12:886831. doi: 10.3389/fonc.2022.886831. eCollection 2022.
Front Oncol. 2022.
PMID: 36132153
Free PMC article.